GLASS is the first global system to incorporate official national data from surveillance of AMR in human (monitoring of resistance and use of antimicrobial medicine), in the food chain, and the environment. It comprises routine and focused surveillance activities, and several survey and studies.
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled. GLASS comprised of several technical modules. These include routine surveillance activities on AMR and AMC, focused surveillance of emerging resistance and AMR in Candida spp., and studies and surveys to estimate AMR burden and related drivers. GLASS is also the data source of the new Sustainable Development Goals (SDGs) AMR indicator.
Most importantly, together with countries and partners, WHO is leading the way towards the further development and consolidation of a functional and comprehensive global surveillance system, which will be able to operate in diverse economic and socio-political
contexts, and still provide timely, reliable, and actionable data. Communication, harmonization, and coordination between international, regional, and national organizations are key priorities for the success of the system.